Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.880
-0.050 (-1.27%)
At close: Mar 24, 2026, 4:00 PM EDT
3.855
-0.025 (-0.65%)
After-hours: Mar 24, 2026, 7:49 PM EDT
Aquestive Therapeutics Market Cap
Aquestive Therapeutics has a market cap or net worth of $473.53 million as of March 24, 2026. Its market cap has increased by 88.56% in one year.
Market Cap
473.53M
Enterprise Value
394.85M
1-Year Change
88.56%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since July 25, 2018, Aquestive Therapeutics's market cap has increased from $393.23M to $473.53M, an increase of 20.42%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 473.53M | -39.92% |
| Dec 31, 2025 | 788.14M | 142.81% |
| Dec 31, 2024 | 324.59M | 140.67% |
| Dec 29, 2023 | 134.87M | 176.07% |
| Dec 30, 2022 | 48.85M | -68.73% |
| Dec 31, 2021 | 156.24M | -13.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tilray Brands | 723.51M |
| BioAge Labs | 692.00M |
| Esperion Therapeutics | 654.87M |
| Eton Pharmaceuticals | 608.99M |
| Ironwood Pharmaceuticals | 495.70M |
| Kamada | 490.33M |
| Emergent BioSolutions | 426.70M |
| Akebia Therapeutics | 380.39M |